(Q44589756)

4 December 2017

title

Microspheres based on inulin for the controlled release of serine protease inhibitors: preparation, characterization and in vitro release (English)

1 reference

4 December 2017

1 reference

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(03)00251-7

11 March 2024

author name string

Nathalie Poulain

1

1 reference

4 December 2017

Isabelle Dez

2

1 reference

4 December 2017

Cecile Perrio

3

1 reference

4 December 2017

Marie-Claire Lasne

4

1 reference

4 December 2017

Marie-Pascale Prud'homme

5

1 reference

4 December 2017

Evelyne Nakache

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

19 September 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14499183

full work available at URL

11 March 2024

https://api.elsevier.com/content/article/PII:S0168365903002517?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(03)00251-7

https://api.elsevier.com/content/article/PII:S0168365903002517?httpAccept=text/plain

11 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(03)00251-7

Journal of Controlled Release

11 March 2024

published in

1 reference

4 December 2017

volume

92

1 reference

4 December 2017

issue

1-2

1 reference

4 December 2017

page(s)

27-38

1 reference

Protease inhibitors: current status and future prospects

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Neuronal cell death and tPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Complexation of the tissue plasminogen activator protease with benzamidine-type inhibitors: interference by the kringle 2 module.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

(Z,Z)-2,7-Bis(4-amidinobenzylidene)cycloheptan-1-one: identification of a highly active inhibitor of blood coagulation factor Xa.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Synthesis, characterization, and structure-activity relationships of amidine-substituted (bis)benzylidene-cycloketone olefin isomers as potent and selective factor Xa inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enz

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Concepts in functional foods: the case of inulin and oligofructose

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Inulin and oligofructose: safe intakes and legal status

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

The adjuvanticity of gamma inulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Modification of inulin with amidoxime groups and coordination with copper(II) ions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Cereport (RMP-7) increases the permeability of human brain microvascular endothelial cell monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Dextran and inulin conjugates as drug carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Inulin hydrogels as carriers for colonic drug targeting. Rheological characterization of the hydrogel formation and the hydrogel network.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Formulation optimization of controlled release diclofenac sodium microspheres using factorial design

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2803%2900251-7

7 January 2021

Molecular analysis of blood vessel formation and disease

3

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(03)00251-7

Synthesis of benzamidine derivatives as inhibitors of clotting enzymes

11 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/S0168-3659(03)00251-7

11 March 2024

Identifiers

1 reference

4 December 2017

1 reference